The Europe clinical trials support services market is projected to rise with a 7.96% CAGR over the assessment years, 2022 and 2030, capturing $11345.14 million in revenue by 2030.
EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET FORECAST 2022-2030
Europe Clinical Trials Support Services Market by Phase (Phase I, Phase II, Phase III, Phase IV) Market by Sponsor (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, Other Sponsors) Market by Service (Clinical Trial Site Management, Administrative Services, Patient Recruitment Management, Regulatory Services, Data Management, Other Services) by Geography
The Europe clinical trials support services market is projected to rise with a 7.96% CAGR over the assessment years, 2022 and 2030, capturing $11345.14 million in revenue by 2030.
The patient recruitment rates are excellent in the European countries because of the presence of a large patient population, especially in Poland, Hungary, etc. Further, the most important part of the clinical trial process is the expert investigators’ high-quality data. The quality of data produced by European investigators matches that of North America, which is considered one of the best globally.
To know more about this report, request a free sample copy
The Europe clinical trials support services market growth estimations include the assessment of Hungary, United Kingdom, Denmark, Spain, Germany, France, Sweden, Italy, and Rest Of Europe. Clinical trials are increasing in the United Kingdom, specifically in England, where the number of clinical research is witnessing rapid growth. Both the number of clinical trials and patient recruitment has surged significantly. Hence, the United Kingdom is a key market where clinical trials can be conducted.
Furthermore, in Germany, clinical trials and comparative effectiveness studies in primary care are rare as biomedical science and technology are more reputed than clinical or health services research. Also, the clinical trials are funded by the industry or a single national program that favors innovation rather than comparative effectiveness studies.
However, in recent years, the number of clinical trials has increased significantly in the country. Further, several CROs offer solutions and services for clinical trial processes to make them efficient. These services are expected to drive market growth significantly during the forecast years.
The Europe clinical trials support services market is segmented into service, phase, and sponsor. Market by sponsor includes pharmaceutical & biopharmaceutical companies, medical device companies, and other sponsors.
The clinical trials of new drugs are an integral part of pharmaceutical and medical research. However, it becomes difficult to execute the process due to its complexity and costs. Therefore, clinical trials are sponsored by various sources, including pharmaceutical and biopharmaceutical companies. The sponsorship makes it easy to execute the trial process. There are various pharmaceuticals and biopharmaceutical companies that sponsor the clinical trial process.
Additionally, clinical trial sponsors play a vital role in determining the viability of clinical research. They monitor the whole research design, facilitate funding sources, and develop beneficiary procedures that help guide the trial processes to get the desired outcome. Other clinical trial sponsors are medical device companies providing the medical devices required during clinical trials.
Clinical trials, a costly and complex process, need sponsors to support them. There are various responsibilities of a sponsor, which include designing the study/draft to address the key research or medical questions, searching for qualified research investigators, ensuring investigators are briefed about the clinical trial study, monitoring the whole clinical trial process and ensuring that all the trials are in compliant with the regulatory frameworks, reporting the results of clinical trials on time, and at last ensuring budget adherence, etc. The other sponsors include government agencies, health care institutions, etc.
Leading players operating in the Europe clinical trials support services market include Alcura Health, ICON PLC, KCR, etc.
ICON is a global leader in the clinical trials support services industry, providing a full range of consulting, clinical development and commercialization services. It covers government & public health solutions, biosimilars, pharmaceuticals, medical devices, and biotech sectors. It has 115 offices in 46 countries covering Europe, Latin America, North America, Asia-Pacific, the Middle East and Africa. ICON PLC was founded in 1990 and is headquartered in Dublin, Ireland.
CDISC Data Standardisation from ICON PLC offers legacy data compliance and conversion checks using Pinnacle 21. It also studies data harmonization, checks in-house tools inventories, etc.
Report Synopsis
|
Report Scope |
Details |
| Market Forecast Years | 2022-2030 |
| Base Year | 2021 |
| Market Historical Years | 2018-2021 |
| Forecast Units | Revenue ($ Million) |
| Segments Analyzed | Phase, Sponsor, and Service |
| Countries Analyzed | United Kingdom, Germany, France, Spain, Italy, Sweden, Denmark, Hungary, and Rest Of Europe |
| Companies Analyzed |
Advanced Clinical, Alcura, Charles River Laboratories Inc, Clinipace, CTI Clinical Trial and Consulting Services Inc, ICON PLC, IQVIA, KCR, Labcorp Drug Development, Medpace, Parexel, PSI CRO, Syneos Health, Worldwide Clinical Trials, WuXi AppTec |
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
- MARKET DYNAMICS
- KEY DRIVERS
- RISING PREVALENCE OF CHRONIC DISEASE & VIRUS OUTBREAKS
- BENEFITS OF CLINICAL TRIAL SUPPORT SERVICES
- KEY RESTRAINTS
- AVAILABILITY OF OPEN-SOURCE/FREEWARE SOFTWARE
- STRINGENT REGULATIONS
- KEY DRIVERS
- KEY ANALYTICS
- IMPACT OF COVID-19 ON CLINICAL TRIALS SUPPORT SERVICES MARKET
- KEY MARKET TRENDS
- PORTER’S FIVE FORCES ANALYSIS
- BUYERS POWER
- SUPPLIERS POWER
- SUBSTITUTION
- NEW ENTRANTS
- INDUSTRY RIVALRY
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- VALUE CHAIN ANALYSIS
- KEY BUYING CRITERIA
- PERFORMANCE
- EASE OF USE
- SECURITY
- COST-EFFECTIVENESS
- REGULATORY FRAMEWORK
- MARKET BY PHASE
- PHASE I
- PHASE II
- PHASE III
- PHASE IV
- MARKET BY SPONSOR
- PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
- MEDICAL DEVICE COMPANIES
- OTHER SPONSORS
- MARKET BY SERVICE
- CLINICAL TRIAL SITE MANAGEMENT
- ADMINISTRATIVE SERVICES
- PATIENT RECRUITMENT MANAGEMENT
- PATIENT RECRUITMENT & REGISTRY SERVICES
- PATIENT RETENTION
- OTHER PATIENT RECRUITMENT MANAGEMENT
- REGULATORY SERVICES
- DATA MANAGEMENT
- OTHER SERVICES
- GEOGRAPHICAL ANALYSIS
- EUROPE
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- UNITED KINGDOM
- GERMANY
- FRANCE
- SPAIN
- ITALY
- SWEDEN
- DENMARK
- HUNGARY
- REST OF EUROPE
- EUROPE
- COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
- MERGERS & ACQUISITIONS
- PRODUCT LAUNCHES & DEVELOPMENTS
- PARTNERSHIPS & AGREEMENTS
- BUSINESS EXPANSIONS & DIVESTITURES
- COMPANY PROFILES
- ADVANCED CLINICAL
- ALCURA
- CHARLES RIVER LABORATORIES INC
- CLINIPACE
- CTI CLINICAL TRIAL AND CONSULTING SERVICES INC
- ICON PLC
- IQVIA
- KCR
- LABCORP DRUG DEVELOPMENT
- MEDPACE
- PAREXEL
- PSI CRO
- SYNEOS HEALTH
- WORLDWIDE CLINICAL TRIALS
- WUXI APPTEC
- KEY STRATEGIC DEVELOPMENTS
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – CLINICAL TRIALS SUPPORT SERVICES
TABLE 2: LIST OF PANDEMIC OUTBREAKS
TABLE 3: LIST OF OPEN-SOURCE SOFTWARE
TABLE 4: LIST OF PARTNERSHIPS
TABLE 5: LAUNCH OF MEDICAL DRUGS
TABLE 6: PROMISING ACQUISITIONS IN THE INDUSTRY
TABLE 7: REGULATORY FRAMEWORK
TABLE 8: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 9: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 10: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 11: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 12: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 13: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 14: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 15: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 16: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 17: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 18: LEADING PLAYERS OPERATING IN EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET
TABLE 19: LIST OF MERGERS & ACQUISITIONS
TABLE 20: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 21: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 22: LIST OF BUSINESS EXPANSIONS & DIVESTITURESÂ Â
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: VALUE CHAIN ANALYSIS
FIGURE 6: KEY BUYING CRITERIA
FIGURE 7: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY PHASE, IN 2021
FIGURE 8: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE I, 2022-2030 (IN $ MILLION)
FIGURE 9: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE II, 2022-2030 (IN $ MILLION)
FIGURE 10: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE III, 2022-2030 (IN $ MILLION)
FIGURE 11: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE IV, 2022-2030 (IN $ MILLION)
FIGURE 12: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY SPONSOR, IN 2021
FIGURE 13: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, 2022-2030 (IN $ MILLION)
FIGURE 14: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY MEDICAL DEVICE COMPANIES, 2022-2030 (IN $ MILLION)
FIGURE 15: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SPONSORS, 2022-2030 (IN $ MILLION)
FIGURE 16: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY SERVICE, IN 2021
FIGURE 17: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY CLINICAL TRIAL SITE MANAGEMENT, 2022-2030 (IN $ MILLION)
FIGURE 18: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY ADMINISTRATIVE SERVICES, 2022-2030 (IN $ MILLION)
FIGURE 19: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, 2022-2030 (IN $ MILLION)
FIGURE 20: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY PATIENT RECRUITMENT MANAGEMENT, IN 2021
FIGURE 21: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT & REGISTRY SERVICES, 2022-2030 (IN $ MILLION)
FIGURE 22: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RETENTION, 2022-2030 (IN $ MILLION)
FIGURE 23: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER PATIENT RECRUITMENT MANAGEMENT, 2022-2030 (IN $ MILLION)
FIGURE 24: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY REGULATORY SERVICES, 2022-2030 (IN $ MILLION)
FIGURE 25: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY DATA MANAGEMENT, 2022-2030 (IN $ MILLION)
FIGURE 26: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SERVICES, 2022-2030 (IN $ MILLION)
FIGURE 27: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 28: UNITED KINGDOM CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 29: GERMANY CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 30: FRANCE CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 31: SPAIN CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 32: ITALY CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 33: SWEDEN CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 34: DENMARK CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 35: HUNGARY CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 36: REST OF EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)Â Â Â Â
- GEOGRAPHICAL ANALYSIS
- EUROPE
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- UNITED KINGDOM
- GERMANY
- FRANCE
- SPAIN
- ITALY
- SWEDEN
- DENMARK
- HUNGARY
- REST OF EUROPE
- EUROPE
- MARKET BY PHASE
- PHASE I
- PHASE II
- PHASE III
- PHASE IV
- MARKET BY SPONSOR
- PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
- MEDICAL DEVICE COMPANIES
- OTHER SPONSORS
- MARKET BY SERVICE
- CLINICAL TRIAL SITE MANAGEMENT
- ADMINISTRATIVE SERVICES
- PATIENT RECRUITMENT MANAGEMENT
- PATIENT RECRUITMENT & REGISTRY SERVICES
- PATIENT RETENTION
- OTHER PATIENT RECRUITMENT MANAGEMENT
- REGULATORY SERVICES
- DATA MANAGEMENT
- OTHER SERVICES
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.